Form 4: Prestige Consumer Healthcare Exec Trades Shares

Sentiment:

Insider Transaction Report


Prestige Consumer Healthcare Inc. reports insider transactions involving Senior VP Operations, Jeffrey Zerillo, with the acquisition and disposition of company stock.

Summary

  • Jeffrey Zerillo, Senior VP Operations at Prestige Consumer Healthcare Inc., engaged in stock transactions on May 7, 2026.
  • Zerillo acquired 351 shares of common stock at a price of $54.59 per share.
  • Concurrently, Zerillo disposed of 305 shares of common stock at a price of $54.36 per share.
  • Following these transactions, Zerillo beneficially owns 42,161 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions without significant positive or negative implications on its own.

Positives

  • Insider acquisition of shares can signal confidence in the company's future prospects.
  • The net effect of the transactions resulted in a slight increase in Zerillo's total beneficial ownership.

Negatives

  • The disposition of shares, even if part of a planned transaction, reduces the insider's direct holding.

Risks

  • The filing does not explicitly detail the reasons for the acquisition and disposition, which could be related to personal financial planning or a pre-arranged trading plan.
  • While not explicitly stated as a risk, any significant selling by insiders can sometimes be interpreted negatively by the market.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Such filings are crucial for investors seeking to understand the actions of company executives and directors, which can sometimes provide insights into their perception of the company's value and future performance.

Stakeholder Impact

  • Shareholders may observe insider transactions as potential indicators of management's confidence in the company, though these specific transactions are routine.
  • Employees may view insider trading activity as a sign of executive engagement with the company's stock performance.

Key Dates

DateDescription
2018-08-07Date of power of attorney on file with the Commission authorizing attorney-in-fact.
2026-05-07Earliest transaction date and date of stock acquisition and disposition.
2026-05-11Date of filing signature.

Keywords

SEC Form 4, Insider Trading, Prestige Consumer Healthcare, PBH, Stock Transaction, Beneficial Ownership, Jeffrey Zerillo, Senior VP Operations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.